scispace - formally typeset
A

Angela Clow

Researcher at University of Westminster

Publications -  191
Citations -  11105

Angela Clow is an academic researcher from University of Westminster. The author has contributed to research in topics: Cortisol awakening response & Cortisol secretion. The author has an hindex of 49, co-authored 181 publications receiving 9980 citations. Previous affiliations of Angela Clow include University of Khartoum & Duke University.

Papers
More filters
Journal ArticleDOI

Suspected non-adherence and weekend versus week day differences in the awakening cortisol response

TL;DR: The pronounced rise in cortisol following awakening holds promise as a bio-marker of variables in the psychosocial domain, but its investigation also presents methodological challenges, which is attempted to address in this study.
Journal ArticleDOI

Isatin: a link between natriuretic peptides and monoamines?

TL;DR: Isatin may mediate a link between monoamines and the natriuretic peptide system, and its analogues may provide new pharmacological tools.
Journal ArticleDOI

Low frequency noise enhances cortisol among noise sensitive subjects during work performance.

TL;DR: This is the first study to demonstrate an effect of moderate levels of noise on neuroendocrine activity and the impact of long-term exposure to moderate noise levels, and particularly low frequency noise, in the workplace deserves further investigation.
Journal ArticleDOI

Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic administration.

TL;DR: Evidence of biochemical changes which parallel the behavioural findings of enhanced dopamine receptor activity that occur during continuous long-term neuroleptic administration to rodents is provided.
Journal ArticleDOI

A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs.

TL;DR: A comparison of the activity of five substituted benzamide drugs in the in vitro models of dopamine receptor activity with their ability to induce catalepsy and to inhibit apomorphine-induced stereotyped behaviour concludes that these compounds act on the cerebral dopamine pathways in a manner which differs from that of classical neuroleptics.